As of 2025-07-19, the Relative Valuation of Sana Biotechnology Inc (SANA) is (17.21) USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.45 USD, the upside of Sana Biotechnology Inc based on Relative Valuation is -486.8%.
The range of the Relative Valuation is (17.09) - (23.78) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
Range | Selected | |
Trailing P/E multiples | 14.1x - 19.6x | 14.7x |
Forward P/E multiples | 13.3x - 21.3x | 13.7x |
Fair Price | (17.09) - (23.78) | (17.21) |
Upside | -484.1% - -634.5% | -486.8% |
Date | P/E |
2025-07-17 | -3.67 |
2025-07-16 | -3.57 |
2025-07-15 | -3.45 |
2025-07-14 | -3.48 |
2025-07-11 | -3.45 |
2025-07-10 | -3.35 |
2025-07-09 | -3.34 |
2025-07-08 | -3.21 |
2025-07-07 | -2.56 |
2025-07-03 | -2.63 |
2025-07-02 | -2.41 |
2025-07-01 | -2.33 |
2025-06-30 | -2.25 |
2025-06-27 | -2.32 |
2025-06-26 | -2.37 |
2025-06-25 | -2.39 |
2025-06-24 | -2.45 |
2025-06-23 | -2.14 |
2025-06-20 | -2.15 |
2025-06-18 | -2.28 |
2025-06-17 | -2.32 |
2025-06-16 | -2.08 |
2025-06-13 | -2.14 |
2025-06-12 | -2.10 |
2025-06-11 | -2.23 |
2025-06-10 | -2.40 |
2025-06-09 | -2.33 |
2025-06-06 | -2.34 |
2025-06-05 | -2.10 |
2025-06-04 | -1.91 |
2025-06-03 | -1.93 |
2025-06-02 | -1.81 |
2025-05-30 | -1.79 |
2025-05-29 | -1.87 |
2025-05-28 | -1.86 |
2025-05-27 | -1.65 |
2025-05-23 | -1.64 |
2025-05-22 | -1.65 |
2025-05-21 | -1.62 |
2025-05-20 | -1.72 |
2025-05-19 | -1.39 |
2025-05-16 | -1.44 |
2025-05-15 | -1.41 |
2025-05-14 | -1.47 |
2025-05-13 | -1.48 |
2025-05-12 | -1.65 |
2025-05-09 | -1.50 |
2025-05-08 | -1.49 |
2025-05-07 | -1.40 |
2025-05-06 | -1.41 |